Vaccines

02 Oct 2020 COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
01 Oct 2020 Vaccibody enters into worldwide license and collaboration agreement with Genentech, a member of the Roche Group, to develop individualized neoantigen cancer vaccines
01 Oct 2020 Ultimovacs Announces Positive Topline Results from Phase I Combination Trial Evaluating Universal Cancer Vaccine, UV1, in Malignant Melanoma Patients
30 Sep 2020 Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
30 Sep 2020 ILiAD Biotechnologies Reports Positive Topline Results from Phase 2b Trial for Pertussis Vaccine Candidate BPZE1
30 Sep 2020 CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate
29 Sep 2020 Altimmune Presents Highlights of Intranasal COVID-19 Vaccine and Therapeutic Programs – AdCOVID™ and T-COVID™ – at the World Vaccine Congress
29 Sep 2020 Imvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
28 Sep 2020 COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
28 Sep 2020 INOVIO reports FDA partial clinical hold for planned Phase 2 / 3 trial of COVID-19 vaccine candidate INO-4800
25 Sep 2020 ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials
25 Sep 2020 Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer
25 Sep 2020 Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis
25 Sep 2020 Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate
25 Sep 2020 Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
23 Sep 2020 Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
23 Sep 2020 Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
23 Sep 2020 St. Louis-based Precision Virologics and India's Biotech leader Bharat Biotech obtain rights to intranasal COVID-19 vaccine technology
21 Sep 2020 OSE Immunotherapeutics Presents Positive Step-1 Phase 3 Results for Tedopi® in NSCLC at the European Society for Medical Oncology Virtual Congress 2020
18 Sep 2020 Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-19
16 Sep 2020 Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101
14 Sep 2020 Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
13 Sep 2020 Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
12 Sep 2020 COVID-19 vaccine AZD1222 clinical trials resumed in the UK
10 Sep 2020 Axon Announces Positive Pre-Clinical Results for its Peptide Vaccine (ACvac1) Against Novel Coronavirus

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top